As of 2025-12-04, the Relative Valuation of Insmed Inc (INSM) is (97.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 211.41 USD, the upside of Insmed Inc based on Relative Valuation is -146.0%.
The range of the Relative Valuation is (95.55) - (97.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.6x - 21.5x | 17.4x |
| Forward P/E multiples | 17.1x - 17.5x | 17.3x |
| Fair Price | (95.55) - (97.90) | (97.17) |
| Upside | -145.2% - -146.3% | -146.0% |
| Date | P/E |
| 2025-11-28 | -37.10 |
| 2025-11-26 | -36.51 |
| 2025-11-25 | -37.32 |
| 2025-11-24 | -36.95 |
| 2025-11-21 | -35.49 |
| 2025-11-20 | -35.65 |
| 2025-11-19 | -36.34 |
| 2025-11-18 | -36.00 |
| 2025-11-17 | -35.25 |
| 2025-11-14 | -34.50 |
| 2025-11-13 | -34.10 |
| 2025-11-12 | -34.71 |
| 2025-11-11 | -34.58 |
| 2025-11-10 | -34.27 |
| 2025-11-07 | -33.87 |
| 2025-11-06 | -33.15 |
| 2025-11-05 | -33.37 |
| 2025-11-04 | -32.63 |
| 2025-11-03 | -33.25 |
| 2025-10-31 | -33.85 |
| 2025-10-30 | -34.68 |
| 2025-10-29 | -29.81 |
| 2025-10-28 | -29.51 |
| 2025-10-27 | -29.29 |
| 2025-10-24 | -28.51 |
| 2025-10-23 | -28.59 |
| 2025-10-22 | -28.64 |
| 2025-10-21 | -29.52 |
| 2025-10-20 | -29.98 |
| 2025-10-17 | -29.60 |
| 2025-10-16 | -29.14 |
| 2025-10-15 | -29.20 |
| 2025-10-14 | -28.81 |
| 2025-10-13 | -29.27 |
| 2025-10-10 | -28.98 |
| 2025-10-09 | -29.35 |
| 2025-10-08 | -28.89 |
| 2025-10-07 | -28.98 |
| 2025-10-06 | -28.26 |
| 2025-10-03 | -28.06 |
| 2025-10-02 | -27.28 |
| 2025-10-01 | -26.30 |
| 2025-09-30 | -25.71 |
| 2025-09-29 | -25.29 |
| 2025-09-26 | -24.47 |
| 2025-09-25 | -24.21 |
| 2025-09-24 | -25.18 |
| 2025-09-23 | -25.96 |
| 2025-09-22 | -25.89 |
| 2025-09-19 | -25.85 |